Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumonia.

ABSTRACT:

Background

Utilization of diagnostics and biomarkers are the second largest cost drivers in the management of patients hospitalized with community-acquired pneumonia (CAP). The present study aimed to systematically assess the inter-hospital variation in these cost drivers in relation to antibiotic use in CAP.

Methods

Detailed resource utilization data from 300 patients who participated in a multicenter placebo-controlled trial investigating dexamethasone as adjunctive treatment for community-acquired pneumonia was grouped into 3 categories: clinical chemistry testing, radiological exams, and microbiological testing. Based on the identified top 5 items per category, average costs were calculated per category and per hospital. Antibiotic de-escalation at day 3 and secondary IC

SUBMITTER: Vestjens SMT 

PROVIDER: S-EPMC6305565 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature